Name | N-(1,3-benzodioxol-5-ylmethyl)-N'-[2-[[5-[(dimethylamino)methyl]furfuryl]thio]ethyl]-2-nitrovinylidenediamine |
---|---|
Synonyms |
Niperotidine
Piperotidine N-(1,3-Benzodioxol-5-ylmethyl)-N'-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-2-nitro-1,1-ethenediamine Piperonylranitidine PiperotidineHCl Piperonylranitidinehydrochloride |
Description | Niperotidine is a histamine H2-receptor antagonist. |
---|---|
Related Catalog | |
Target |
histamine H2 receptor[1] |
In Vivo | Niperotidine (piperonyl-ranitidine) is a H2 blocking agent. Niperotidine is a H2-receptor antagonist structurally related to ranitidine. After oral administration, it reaches a plasmatic peak within 60-120 min and is eliminates either in the urine or in the faeces, with an enterohepatic circulation[2]. |
References |
Density | 1.268g/cm3 |
---|---|
Boiling Point | 566.324ºC at 760 mmHg |
Molecular Formula | C20H26N4O5S |
Molecular Weight | 434.50900 |
Flash Point | 296.302ºC |
Exact Mass | 434.16200 |
PSA | 130.02000 |
LogP | 4.06310 |
Index of Refraction | 1.591 |
Storage condition | 2-8℃ |